Anti-cancer Compound Library-Ⅱ
Catalog No.L7100
Offered in 96 or 384 well plate format

A unique collection of 921 compounds with anticancer activity which has been verified by broad institute,half of the compounds are non-oncology drugs.
Selleck Chemicals compound library contributes and expedites
the investigation of treatments against COVID19
The researchers at the National Institute of Infectious Diseases, in Japan, successfully found anti-COVID19 drugs within 3 months of
screening FDA-approved drug library from Selleck Chemicals. They have already published this article doi: 10.1101/2020.04.14.039925.
You Could Select:
Anti-cancer Compound Library-Ⅱ Contents
Case Studies using Selleck Compound Libraries
-
Application of Epigenetics Compound Library in acute lymphoblastic leukemia
Blood. 2019 17;134(16):1323-1336
Description & Advantages
•The Broad Institute tested 4,518 drugs across 578 human cancer cell lines and found large number of non-oncology drugs selectively inhibited subsets of cancer cell lines(PMID:32613204)
•A unique collection of 921 compounds with anticancer activity which has been verified by broad institute used for high throughput screening(HTS) and high content screening(HCS)
•Targets DNA/RNA Synthesis,HDAC,EGFR,Aurora Kinase,Topoisomerase,etc.
•Some compounds have been approved by the FDA
•Structurally diverse,medicinally active,and cell permeable
•Rich documentation with structure and bioactivity information
•NMR and HPLC validated to ensure high purity
Product Details
Formulation: | 857 compounds pre-dissolved in 10mM DMSO, 20 compounds pre-dissolved in 10mM water, 42 compounds pre-dissolved in 2mM DMSO and 2 compounds pre-dissolved in 2mM water |
---|---|
Container: | 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode |
Stability: | in DMSO |
in DMSO | |
Shipping: | Blue ice or dry ice |